Pinion Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.65M Buy
1,379
+131
+10% +$134K 0.31% 51
2026
Q1
$1.15M Buy
1,248
+482
+63% +$489K 0.27% 62
2025
Q4
$823K Buy
766
+468
+157% +$447K 0.2% 76
2025
Q3
$246K Sell
298
-56
-16% -$41.7K 0.07% 150
2025
Q2
$276K Buy
+354
New +$275K 0.1% 141

Other funds holding LLY

Pinion Investment Advisors's LLY Position: Q2 2026 in Review

Pinion Investment Advisors increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $134K and bringing the position to 1,379 shares worth $1.65M. The position accounts for 0.31% of the portfolio, ranked #51.

Pinion Investment Advisors first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Pinion Investment Advisors held 1,379 shares of Eli Lilly worth $1.65M as of Q2 2026.
  • Pinion Investment Advisors bought 131 Eli Lilly shares in Q2 2026, an estimated $134K.
  • Eli Lilly made up 0.31% of Pinion Investment Advisors's portfolio in Q2 2026, its #51 holding.
  • Pinion Investment Advisors first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Pinion Investment Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.